Financial Street Property Co., Limited
1502.HK News Today: Stay Updated with the Latest Financial Street Property Co., Limited News in Real Time
Find 1502.HK news now at Meyka AI. Stay informed with the latest Financial Street Property Co., Limited stocks updates, including price news, market analysis, and expert insights.

Prince Harry April 25: Ukraine Visit Sparks Diplomatic Tensions
Prince Harry visits Ukraine April 25 to address security forum, makes political statements against Russia and Trump, raising royal diplomacy concerns.

CNQ.TO Stock Falls 2.44% in After-Hours Trading on TSX
CNQ.TO declined 2.44% to C$60.69 after-hours. Canadian Natural Resources shows mixed technicals with strong fundamentals and A- rating.

FSV.TO FirstService Earnings Beat: EPS Surges 7.44%
FirstService Corporation (FSV.TO) beats Q1 2026 earnings with $1.30 EPS vs $1.21 estimate and $1.80B revenue.

TER Stock Surges 4.26% in After-Hours Trading on April 24
Teradyne (TER) gains $17.09 to $418.08 in after-hours trading. NASDAQ semiconductor test equipment leader shows strong momentum with B+ grade.

DHARAN.NS Stock Flat at ₹0.16 in Pre-Market April 25, 2026
DHARAN.NS stock holds steady at ₹0.16 in pre-market trading. Volume surges 10.8% above average. Real Estate sector analysis inside.

Gilles Bélanger Quits CAQ April 24: Minister Exits After Remaniement
Gilles Bélanger quits CAQ caucus after losing ministerial post. Former Cybersecurity Minister exits as independent amid digital health concerns.

ALGTR.PA stock surges 20.8% as Groupe Tera gains momentum on EURONEXT
ALGTR.PA stock jumped 20.8% to €4.30 on April 24, 2026. Groupe Tera SA shows strong trading volume despite challenging fundamentals and D+ rating.

Solana USD Drops 1.58% Daily: $71.94 Monthly Target
Solana USD falls 1.58% daily to $86.35. Technical analysis shows neutral RSI at 48.43. Monthly forecast targets $71.94 amid market volatility.

ADXN.SW Stock Surges 8.7% as Addex Therapeutics Nears Earnings
ADXN.SW stock jumps 8.7% to CHF0.0498 on SIX ahead of April 27 earnings. Biotech firm faces profitability challenges but shows momentum.